Quarterly report [Sections 13 or 15(d)]

Revenues from Contracts and Significant Customers (Tables)

v3.25.2
Revenues from Contracts and Significant Customers (Tables)
6 Months Ended
Jun. 30, 2025
Revenues from Contracts and Significant Customers  
Schedule of disaggregation of total revenues

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

Six Months Ended June 30, 

($ in thousands)

    

2025

    

2024

    

2025

    

2024

Emrosi

​

$

2,795

​

$

—

​

$

4,865

​

$

—

Qbrexza

​

​

6,949

​

​

6,836

​

​

12,110

​

​

11,853

Accutane

​

​

3,395

​

​

5,719

​

​

7,050

​

​

11,538

Amzeeq

​

​

879

​

​

1,205

​

​

1,979

​

​

1,960

Zilxi

​

​

256

​

​

369

​

​

682

​

​

642

Other / legacy product revenue

​

​

735

​

​

726

​

​

1,462

​

​

1,892

Revenue – related party

​

 

—

​

 

41

​

 

—

​

 

41

Other revenue

​

​

1,404

​

​

—

​

​

1,404

​

 

—

Total net revenue

​

$

16,413

​

$

14,896

​

$

29,552

​

$

27,926